David West, Proscia’s co-founder and CEO, said the funding will be used by the company to invest in product development, further scale its commercial operations, accelerate the adoption of computational pathology, and to expand its workforce.
The company currently has about 100 employees, West said, and it expects to add another 40 over the next six months.
Featured Story:
Latest Articles
October 1, 2024